DILTIAZEM HYDROCHLO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP21F3069, issued on July 23, 2026, to supply diltiazem hydrochloride identified by NSN 6505015055281. This award is executed as a delivery order under the master contract SPE2DX15D9383, with the total contract value to be detailed in the official award documentation. The procurement is fully funded by the Department of Defense and falls under federal procurement channels without any specified set-aside classification or NAICS code. Performance is expected to occur within the United States, though no specific delivery location is provided. The contract will supply a critical pharmaceutical agent used in military medical operations, and all information and documentation can be accessed through the DIBBS portal using the provided UI link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
